You have 9 free searches left this month | for more free features.

2C19

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • Coronary Artery Disease
  • (no location specified)
Oct 22, 2023

CYP2C19 Genetic Variants Trial in Stanford (Limonene)

Recruiting
  • CYP2C19 Genetic Variants
  • Limonene
  • Stanford, California
    Stanford School of Medicine
Aug 18, 2022

Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)

Recruiting
  • Antipsychotic Induced Weight Gain
  • Non-alcoholic Steatohepatitis (NASH)
  • Miami, Florida
    Site 01
Feb 3, 2023

Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

Recruiting
  • Acute Coronary Syndrome
  • CYP2C19 Polymorphism
  • Nieuwegein, Utrecht, Netherlands
    St. Antonius Hospital
Jun 27, 2023

Rheumatoid Arthritis Trial in Sofia, Chisinau (Olokizumab, Omeprazole, Caffeine)

Completed
  • Rheumatoid Arthritis
  • Sofia, Bulgaria
  • +1 more
Nov 17, 2022

Healthy Trial (Voriconazole 200mg, FluvoxaMINE 50 Mg Oral Tablet, Omeprazole 10 MG Oral Tablet)

Not yet recruiting
  • Healthy
  • Voriconazole 200mg
  • +2 more
  • (no location specified)
Feb 21, 2022

Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

Not yet recruiting
  • Coronary Artery Disease
  • Platelet Reactivity
  • (no location specified)
Mar 7, 2023

Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

Completed
  • Rheumatoid Arthritis
  • SHR0302 Tablets
  • +5 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 21, 2022

Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

Not yet recruiting
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Genetic testing
  • Singapore, Singapore
    Singapore General Hospital
Mar 9, 2023

Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

Not yet recruiting
  • Liver Cirrhosis
  • (no location specified)
Feb 14, 2023

Healthy Trial in Cypress, South Miami, San Antonio (Imlunestrant, Repaglinide, Omeprazole)

Completed
  • Healthy
  • Cypress, California
  • +2 more
Nov 23, 2022

(MTHFR C677T) in COVID-19patients

Completed
  • COVID 19 Associated Coagulopathy
  • RT- PCR of 2 ml EDTA blood sample to determine MTHFR C677T genotypes
  • Cairo, Egypt
    Ain Shams University
Jan 9, 2023

Obesity, GERD Trial in Kansas City (Pantoprazole)

Completed
  • Obesity
  • GERD
  • Kansas City, Missouri
    Children's Mercy Hospital and Clinics
Oct 26, 2021

Peripheral Arterial Disease Trial in Netherlands (Direct CYP2C19 genotyping, CYP2C19 genotyping at the end of the study, Poor

Recruiting
  • Peripheral Arterial Disease
  • Direct CYP2C19 genotyping
  • +4 more
  • Apeldoorn, Netherlands
  • +10 more
Apr 19, 2022

Healthy Volunteers Trial in Austin (Fedratinib, Fluconazole)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD Phase 1 Clinic
Nov 17, 2021

Personalized Antiplatelet Therapy in CAD Patients

Completed
  • Coronary Artery Disease
    • (no location specified)
    Dec 14, 2021

    SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,

    Active, not recruiting
    • SARS-CoV2 COVID-19
    • COVIGEN C19 0.8 mg ID or Placebo ID
    • +3 more
    • Randwick, New South Wales, Australia
    • +2 more
    Nov 17, 2022

    Covid19 Trial in New York (C144-LS and C-135-LS)

    Completed
    • Covid19
    • C144-LS and C-135-LS
    • New York, New York
      The Rockefeller University
    Aug 2, 2022

    COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

    Active, not recruiting
    • COVID-19
    • +2 more
    • VB10.2129
    • VB10.2210
    • Bergen, Norway
    • +1 more
    Jan 6, 2023

    COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium

    Terminated
    • COVID-19
    • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    • C19-IG 20%
    • 0.9% Sodium chloride
    • L'Hospitalet de Llobregat, Barcelona, Spain
    • +11 more
    Nov 8, 2022

    Long-term Effects of COVID-19

    Recruiting
    • COVID-19
    • SAR-CoV-2
    • (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)
    • 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)
    • Jacksonville, Florida
      Mayo Clinic Florida
    May 31, 2022

    Healthy Volunteers Trial in Long Beach, Berlin (AZD9833, Midazolam, Omeprazole)

    Recruiting
    • Healthy Volunteers
    • Long Beach, California
    • +1 more
    Jul 26, 2022

    Diabetes, Type 2 Trial in Sarajevo (Omeprazole, Placebo oral tablet, Gliclazide)

    Completed
    • Diabetes Mellitus, Type 2
    • Sarajevo, Bosnia and Herzegovina
      General Hospital Prim. Dr. Abdulah Nakas
    Jul 19, 2021

    COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • AZD9838
    • Licensed mRNA vaccine
    • Long Beach, California
    • +4 more
    Nov 24, 2023

    Liver Metabolizing Enzyme in Taiwanese Patients

    Completed
    • Invasive Fungal Infections
    • Blood drawn (lab data)
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 8, 2022